Score Breakdown
Offering Ability
40
Cash Runway—
Float Risk—
Warrant Exposure
40
Convertible Debt
60
Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
model est. 39%
🔄 Reverse Split
model est. 55%
• 50-day avg $0.39 below $1 exchange minimum
🔁 Convertible Conversion
model 40%
• Significant convertible debt: 22% potential dilution
• Elevated convertible risk (60/100)
Market Data
Market Cap$6.57M
Shares Outstanding13.84M
FloatN/A
Cash$2.12M
DebtN/A
Short InterestN/A
Institutional Holdings
1 institutional holders · 231 shares
#1
BARCLAYS PLC
231 shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest312.3K
Days to Cover8.5
% of FloatN/A
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL WARRANT
2025-09-30
xbrl
XBRL CONVERTIBLE
2023-12-31
4
INSIDER TRANSACTION
2026-02-03
3
FORM3
2026-01-14
3
FORM3
2026-01-13
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual SYRA Dilution Snapshot
Syra Health Corp. (SYRA) has a DilutionScore of 29/100, rated Medium dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for SYRA: 4 on 2026-02-03; 3 on 2026-01-14; 3 on 2026-01-13.
- Score coverage note: Float Risk is excluded because public-float data is unavailable.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — MEDIUM Risk
Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:
📖 Dilution Education
Score Coverage Note
- Float Risk is excluded because public-float data is unavailable.